Follow The Filings

IVF INVO Fertility

INVO Fertility earnings company data as of 4:49 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 16 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — 0.35 —
Rev — — —

Insider trades

Open-market buys and sales by IVF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IVF insider trades
  • None no insider bought on the open market
  • $6 sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Matthew K Szot Director
    Sale
    $6 4 shares at $1.52 57% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025

Also filed in the last 12 months, not counted as buying or selling: 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 7.01,8.01,9.01
8-K 2.02,9.01
SCHEDULE 13G/A —
10-Q
SCHEDULE 13G —
424B3
8-K 1.01,3.02,5.03,5.07,9.01
S-1
8-K 1.01,8.01
DEF 14A
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
10-K/A
8-K 4.02,9.01
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 3.01,7.01,9.01
SCHEDULE 13G —
8-K 5.03,8.01,9.01
8-K 1.01,2.01,3.02,5.03,8.01,9.01
SCHEDULE 13G —
424B3

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.